Florida Consumer Lawyer BLOGFlorida Consumer Lawyer BLOG

New Study Shows Dangerous Actos Side Effects

August 13th, 2012

Actos is a drug usually prescribed to patients with diabetes to aid in their insulin uptake. However, many ill patients have filed lawsuits against Takeda Pharmaceuticals, the drug’s manufacturer, due to allegations of deadly side effects. A recent study adds legitimacy to the patients’ claims.

New Study

A study performed by Jeffrey A. Johnson found that people with diabetes who take Actos are 22 percent more likely to develop bladder cancer than those who abstain from the drug. Of 2.6 million patients taking Actos, 3,643 of them developed bladder cancer.

Actos is intended to help diabetics by making the body’s cells more susceptible to insulin, a growth hormone. Unfortunately, malignant cancer cells also feed on insulin, so Actos can fuel the growth of cancer cells.

The Food and Drug Administration (FDA) says that using Actos for over a year can increase the risk of bladder cancer by 40 percent.


A federal Actos court date is scheduled for November 3, 2014. Due to the sheer number of people affected, the court has scheduled a second Actos liability court date for July 8, 2015.

The drug may have even more severe side effects according to a whistleblower lawsuit filed by Dr. Helen Ge, a former employee. She claims her supervisors advised her to smooth over some of the drug’s more harmful side effects in various reports, which she says includes epilepsy, heart trouble, schizophrenia and suicide.

If you suffered a serious illness after taking Actos or if you lost a family member who was taking the drug, call us at (305) 379-0305. You can also submit a contact form or leave a comment below. There is no charge to discuss your potential case.

Sarelson Law FirmMiami class action attorneys

Is Your Bank Cheating You?

August 3rd, 2012

Earlier this week we wrote about how the Consumer Financial Protection Bureau (CFPB), the federal watchdog agency responsible for protecting American consumers against illegal and unethical practices, took a stand against Capital One for misleading its customers. In the wake of the CFPB’s first major action, we want to help you determine if your bank is guilty of the same charges.


  • Has your bank coerced you into adding an extra service?
    • Did a representative say that it was mandatory?
    • Did a representative promise a better credit score if you added said feature?
    • Did a representative say it was free or cheap? Check your bill; it might cost more than he or she said.
  • Has your bank enrolled you in extra services without your consent?
  • Has your bank offered you services that you do not qualify for?
  • Is your bank giving you the run-around when you try to cancel services, especially those that you were automatically enrolled in or do not qualify for?
  • Do you feel that a bank representative pressured you into adding extra services?

If your bank or credit union has participated in any of the above activities, you may be able to recover the money you lost. After Capital One misled millions into paying more for extraneous services, the customers will get that money back. You could regain money lost in deceptive sales tactics by giving us a call: 305-379-0305. We offer free consultations to discuss your situation and assess your best options.

Sarelson Law FirmMiami class action lawyers

Consumer Financial Protection Bureau Scores $210 Million Victory Against Capital One

July 30th, 2012

Just after the two-year anniversary of the Dodd-Frank Act, which established financial regulations to prevent another stock market crash, the Consumer Financial Protection Bureau (CFPB) ordered Capital One to pay $210 million in fines for engaging in deceptive sales tactics.

The CFPB took action after officials listened in on live and recorded phone calls from Capital One customer sales reps. CFPB officials noticed call center reps misleading customers in the following ways:

  • Telling customers that certain optional features were mandatory
  • Telling customers that extra features would improve their credit score and lead to a higher credit limit
  • Telling customers that some services were free or less expensive than they actually were
  • Offering services to customers who did not qualify for them, and failing to remove the services in a timely manner after customers called to complain
  • Automatically enrolling customers into certain programs without the customer’s consent

Most of the money ($150 million) will go to 2.5 million customers tricked by the bank’s hard sales tactics. The CFPB gets $25 million, and $35 million will go to the Office of the Comptroller of the Currency, the federal body in charge of policing financial institutions.

The CFPB was initiative by the Dodd-Frank Act to hold companies responsible for taking advantage of consumers.

We applaud the CFPB in its first major action against a company that misleads its customers. Capital One violated the trust of its clients, and issued an apology in addition to the fines. Check back Friday to find out if your bank is engaging in similar illegal tactics. Visit our website for more information about consumer protection.

Sarelson Law FirmMiami litigation attorneys